BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 12621847)

  • 21. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of needle localization in the diagnosis of occult breast cancer.
    Amin EA; Meyer JE
    J Ky Med Assoc; 1988 May; 86(5):229-34. PubMed ID: 2838558
    [No Abstract]   [Full Text] [Related]  

  • 23. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
    Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
    AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic and histopathologic correlation of nonpalpable lesions of the breast and the reliability of frozen section diagnosis.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; van der Sluis RF; Lubbers EJ; de Boer HH
    Surg Gynecol Obstet; 1987 Dec; 165(6):523-9. PubMed ID: 2825366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of the site and extent of breast carcinoma].
    Kessler M; Milz P; Sittek H; Schnarkowski P; Schmidt D; Bredl T; Reiser M
    Aktuelle Radiol; 1995 Jan; 5(1):47-52. PubMed ID: 7888430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection.
    Ikeda DM; Birdwell RL; Daniel BL
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):345-56, vii. PubMed ID: 11493424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ductoscopy and intraductal vacuum assisted biopsy in women with pathologic nipple discharge.
    Hünerbein M; Raubach M; Gebauer B; Schneider W; Schlag PM
    Breast Cancer Res Treat; 2006 Oct; 99(3):301-7. PubMed ID: 16752074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MRI outstands mammogram in sensitivity of breast ductal carcinoma in situ:an analysis of 122 cases].
    Yu QX; Chen XS; Wu JY; Han BS; He JR; Zhu L; Chen WG; Li YF; Tan L; Chai WM; Wang DB; Fei XC; Yuan F; Jin XL; Shen KW; Li HW
    Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):26-9. PubMed ID: 23578423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic Resonance Female Breast Imaging (MRFBI) - Evaluation of the Changes in Signal Intensity over Time Pre- and Post-administration of 0.2 mmol/kg Gd-DTPA.
    Schedel H; Oellinger H; Kohlschein P; Siewert C; Hadijuana J; Blohmer JU; Kissner T; Felix R
    Zentralbl Gynakol; 2002 Feb; 124(2):104-10. PubMed ID: 11935495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillary lesions of the breast: selected diagnostic and management issues.
    Collins LC; Schnitt SJ
    Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of needle core biopsy in the histological characterisation of mammary lesions.
    Cipolla C; Fricano S; Vieni S; Amato C; Napoli L; Graceffa G; Latteri S; Latteri MA
    Breast; 2006 Feb; 15(1):76-80. PubMed ID: 16473738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast MRI wire-guided excisional biopsy: specimen size as compared to mammogram wire-guided excisional biopsy and implications for use.
    Javid SH; Carlson JW; Garber JE; Birdwell RL; Lester S; Lipsitz S; Golshan M
    Ann Surg Oncol; 2007 Dec; 14(12):3352-8. PubMed ID: 17849165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
    Kuhl CK; Schrading S; Bieling HB; Wardelmann E; Leutner CC; Koenig R; Kuhn W; Schild HH
    Lancet; 2007 Aug; 370(9586):485-92. PubMed ID: 17693177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ.
    Yang WT; Tse GM
    AJR Am J Roentgenol; 2004 Jan; 182(1):101-10. PubMed ID: 14684521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ductal carcinoma in situ of the breasts: review of MR imaging features.
    Greenwood HI; Heller SL; Kim S; Sigmund EE; Shaylor SD; Moy L
    Radiographics; 2013 Oct; 33(6):1569-88. PubMed ID: 24108552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ductal enhancement on MR imaging of the breast.
    Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
    AJR Am J Roentgenol; 2003 Aug; 181(2):519-25. PubMed ID: 12876038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
    Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
    J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six cases showing radial scar/complex sclerosing lesions of the breast detected by breast cancer screening.
    Inoue S; Inoue M; Kawasaki T; Takahashi H; Inoue A; Maruyama T; Matsuda K; Kunitomo K; Murata S; Fujii H
    Breast Cancer; 2008; 15(3):247-51. PubMed ID: 18311480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.